Login

Consolidated Balance Sheets (Current Period Unaudited)

In millions of USD, except per-share amounts
Q2 FY2021
As of Jun 30, 2021
Q1 FY2021
As of Mar 31, 2021
Q4 FY2020
As of Dec 31, 2020
Q3 FY2020
As of Sep 30, 2020
Q2 FY2020
As of Jun 30, 2020
Q1 FY2020
As of Mar 31, 2020
Q4 FY2019
As of Dec 31, 2019
Q3 FY2019
As of Sep 30, 2019
Q2 FY2019
As of Jun 30, 2019
Q1 FY2019
As of Mar 31, 2019
Q4 FY2018
As of Dec 31, 2018
Q3 FY2018
As of Sep 30, 2018
Q2 FY2018
As of Jun 30, 2018
Q1 FY2018
As of Mar 31, 2018
Q4 FY2017
As of Dec 31, 2017
Q3 FY2017
As of Sep 30, 2017
Q2 FY2017
As of Jun 30, 2017
Q1 FY2017
As of Mar 31, 2017
Q4 FY2016
As of Dec 31, 2016
Q3 FY2016
As of Sep 30, 2016
Assets
Cash and cash equivalents
Restricted cash
Contracts and accounts receivable
Due from affiliates
Real estate inventories
Investment in unconsolidated joint ventures
Deferred tax asset, net
Other assets
Total assets
Liabilities and equity
Accounts payable
Accrued expenses and other liabilities
Due to affiliates
Notes payable
Total notes payable
Unsecured revolving credit facility
Revolving Credit Facility
Total unsecured revolving credit facility
Senior notes, net
Total liabilities
Stockholders' equity:
Preferred stock, $0.01 par value, 50,000,000 shares authorized, no shares outstanding
Common stock, $0.01 par value, 500,000,000 shares authorized, 18,160,613 and 18,122,345, shares issued and outstanding as of June 30, 2021 and December 31, 2020, respectively
Additional paid-in capital
Retained earnings
Total stockholders' equity
Non-controlling interest in subsidiary
Total equity
Total liabilities and stockholders' equity

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support